See the DrugPatentWatch profile for cosentyx

The decision to adjust vaccine timing before receiving Cosentyx (secukinumab) depends on various factors, including individual patient circumstances and medical advice. Cosentyx is a biologic medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.

According to the Cosentyx prescribing information [1], live vaccines should not be administered during treatment with Cosentyx. Live vaccines, such as the MMR vaccine, can be weakened by the medication, potentially leading to reduced vaccine effectiveness.

On the other hand, inactivated vaccines, such as the flu vaccine, can be administered while taking Cosentyx. However, it is essential to consult with a healthcare provider before receiving any vaccine while taking Cosentyx to determine the best course of action.

DrugPatentWatch.com [2] notes that Cosentyx is a biologic medication with a complex mechanism of action. As such, it is crucial to follow the recommended dosing schedule and administration guidelines to ensure optimal treatment outcomes.

In conclusion, it is recommended to consult with a healthcare provider before adjusting vaccine timing before receiving Cosentyx. The decision should be based on individual patient circumstances and medical advice.

Sources:

[1] Cosentyx Prescribing Information. (2022). Retrieved from <https://www.cosentyx.com/hcp/prescribing-information/>

[2] DrugPatentWatch.com. (n.d.). Cosentyx (Secukinumab). Retrieved from <https://www.drugpatentwatch.com/drugs/cosentyx-secukinumab>

Note: It is essential to consult with a healthcare provider before making any changes to vaccine timing or receiving any vaccine while taking Cosentyx.